Article

Enhanced Generation of Induced Pluripotent Stem Cells from a Subpopulation of Human Fibroblasts

Johns Hopkins University, United States of America
PLoS ONE (Impact Factor: 3.53). 09/2009; 4(9):e7118. DOI: 10.1371/journal.pone.0007118
Source: PubMed

ABSTRACT The derivation of induced pluripotent stem cells (iPSCs) provides new possibilities for basic research and novel cell-based therapies. Limitations, however, include our current lack of understanding regarding the underlying mechanisms and the inefficiency of reprogramming.
Here, we report identification and isolation of a subpopulation of human dermal fibroblasts that express the pluripotency marker stage specific embryonic antigen 3 (SSEA3). Fibroblasts that expressed SSEA3 demonstrated an enhanced iPSC generation efficiency, while no iPSC derivation was obtained from the fibroblasts that did not express SSEA3. Transcriptional analysis revealed NANOG expression was significantly increased in the SSEA3 expressing fibroblasts, suggesting a possible mechanistic explanation for the differential reprogramming.
To our knowledge, this study is the first to identify a pluripotency marker in a heterogeneous population of human dermal fibroblasts, to isolate a subpopulation of cells that have a significantly increased propensity to reprogram to pluripotency and to identify a possible mechanism to explain this differential reprogramming. This discovery provides a method to significantly increase the efficiency of reprogramming, enhancing the feasibility of the potential applications based on this technology, and a tool for basic research studies to understand the underlying reprogramming mechanisms.

Download full-text

Full-text

Available from: Renee A Reijo Pera, Dec 05, 2014
0 Followers
 · 
81 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Studies of Parkinson's disease (PD) have been hindered by lack of access to affected human dopaminergic (DA) neurons. Here, we report generation of induced pluripotent stem cells that carry the p.G2019S mutation (G2019S-iPSCs) in the Leucine-Rich Repeat Kinase-2 (LRRK2) gene, the most common PD-related mutation, and their differentiation into DA neurons. The high penetrance of the LRRK2 mutation and its clinical resemblance to sporadic PD suggest that these cells could provide a valuable platform for disease analysis and drug development. We found that DA neurons derived from G2019S-iPSCs showed increased expression of key oxidative stress-response genes and α-synuclein protein. The mutant neurons were also more sensitive to caspase-3 activation and cell death caused by exposure to stress agents, such as hydrogen peroxide, MG-132, and 6-hydroxydopamine, than control DA neurons. This enhanced stress sensitivity is consistent with existing understanding of early PD phenotypes and represents a potential therapeutic target.
    Cell stem cell 03/2011; 8(3):267-80. DOI:10.1016/j.stem.2011.01.013 · 22.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper describes the application of evolvable hardware to the design of a widely-used power electronics device, comparing the automatically synthesized circuits with those designed using the latest conventional design methods. With the increasing need by digital devices for low voltage and high current battery-driven power supplies, considerable research effort in recent years has been spent on high-efficiency DC-DC power converters. The best solution so far has been the use of control-driven synchronous rectifiers in these converters, which can yield efficiencies in the range of 91 to 92 percent. It is possible, however, that other designs could be found which might result in even higher efficiencies, with lower voltage and higher current outputs. Since the mid 1990's, the use of evolutionary algorithms to design a variety of hardware systems has seen rapid and successful growth, frequently resulting in novel designs not possible by conventional design techniques. In an exploratory experiment we will apply evolutionary methods to design a high efficiency, low voltage, high current output DC-DC converter. The performance of this evolved design will be compared with that of the control-driven synchronous rectifier converter, designed using conventional electronics design methods. While evolutionary design will not remove the fundamental design challenges, it is hoped that improved design approaches will emerge from the experiments. The paper explains why achieving high efficiencies in low output voltage DC-DC converters faces fundamental problems. A variety of solutions developed in the last 20 years are examined. Then the development of evolutionary processes starting in the 1950's is described. The invention of the field programmable gate array (FPGA) in the 1980's enabled extension of the evolutionary process to hardware design. Following this section, the need for and invention of hardware platforms more suitable for hardware evolution than the FPGA is reviewed. The series of experiments which is the objective of this paper is described, followed by comparisons which will be made between evolved and conventionally designed low voltage output DC-DC converters. The comparisons will be based on: maximum achieved efficiency; number of runs requi- red to evolve to maximum efficiency; complexity of required hardware circuits; and other parameters found to be important as the experiments are performed. Sufficient details of the hardware and software used, and a complete list of references will be given, to enable duplication of the experiments and results by other independent research workers. On completion of the experiments, results will be analyzed and conclusions drawn as to whether the use of evolutionary design methods result in advantages over conventional design techniques.
    Telecommunications Energy Conference, 2004. INTELEC 2004. 26th Annual International; 10/2004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pluripotent stem cells have been derived from various embryonic, fetal and adult sources. Embryonic stem cells (ESCs) and parthenogenic ESCs (pESCs) are derived from the embryo proper while embryonic germ cells (EGCs), embryonal carcinoma cells (ECCs), and germ-line stem cells (GSC) are produced from germ cells. ECCs were the first pluripotent stem cell lines established from adult testicular tumors while EGCs are generated in vitro from primordial germ cells (PGCs) isolated in late embryonic development. More recently, studies have also demonstrated the ability to produce GSCs from adult germ cells, known as spermatogonial stem cells. Unlike ECCs, the source of GSCs are normal, non-cancerous adult tissue. The study of these unique cell lines has provided information that has led to the ability to reprogram somatic cells into an ESC-like state. These cells, called induced pluripotent stem cells (iPSCs), have been derived from a number of human fetal and adult origins. With the promises pluripotent stem cells bring to cell-based therapies there remain several considerations that need to be carefully studied prior to their clinical use. Many of these issues involve understanding key factors regulating their generation, including those which define pluripotency. In this regard, the following article discusses critical aspects of pluripotent stem cell derivation and current issues about their therapeutic potential.
    Stem Cells and Cloning: Advances and Applications 12/2009; 3:13-27.